Enzyme Regulation and Allosteric Control

Allosteric Effects in Enzymes

  • Allosteric enzymes can be studied using kinetics to see their effects.
  • Allosteric modulators are not necessarily binding at the enzyme's active site; some even bind substrates.
  • Substrate binding can change the enzyme's conformation, affecting subsequent substrate binding (positive or negative modulation).

Regulation of Enzyme Activity

  • Enzyme activity can be positively or negatively modulated.
  • Inhibitor design must account for involvement in multiple pathways.
  • Kinases transiently form covalent bonds during phosphorylation.
  • Enzymes may require processing to become active (e.g., chymotrypsin, insulin).
  • Activity regulation can be fine-tuned (pH changes) or irreversible (covalent bond formation).
  • Reactions requiring quick responses often involve covalent bond formation or cleavage.

Allosteric Regulation

  • Responses can be homotropic (substrate-related) or heterotropic (different compound).
  • Conformational changes occur between tense (T) and relaxed (R) states.
  • Allosteric modulators are distinct from uncompetitive and mixed inhibitors.
  • Allosteric modulators usually require a multimeric protein (dimer).

Aspartate Transcarbamoylase (ATCase) Example

  • ATCase is involved in pyrimidine biosynthesis.
  • It transfers a carbamoyl group to aspartate.
  • Has 12 polypeptides forming 6 catalytic and 6 regulatory subunits.
  • Senses ATP (positive regulator) and CTP (negative regulator).
  • CTP inhibits by changing enzyme conformation when CTP levels are high.
  • ATP promotes the reaction; competition between ATP and CTP binding affects activity.
  • Kinetic curves change shape (sigmoidal to hyperbolic) without altering V<em>maxV<em>{max}, only K</em>mK</em>m.

Covalent Modifications

  • Examples: phosphorylation, adenylation, acetylation, myristoylation, ubiquitylation, ribosylation, methylation.
  • Each modification adds different properties (charge, hydrophobicity).
  • Phosphorylation by kinases is common but challenging to inhibit due to ATP binding.
  • Inhibitors can mimic the protein substrate to target specific kinases by recognizing the amino acid pattern around the phosphorylation site.

Blood Clotting Cascade

  • Involves cleavage of fibrinogen to form a fibrin mesh, stopping bleeding.
  • Irreversible cascade with multiple serine proteases activating downstream factors.
  • Thrombin plays a role in cleaving different factors for a quick response.